HKCeND is a groundbreaking brand that focuses on cutting-edge research in the field of neurodegenerative diseases, with a particular emphasis on Alzheimer's disease. Their mission is to translate their discoveries into innovative diagnostics and therapeutics that can make a real impact in this area. With the challenge of global population aging in mind, HKCeND is dedicated to delivering novel diagnostic tools and therapeutic strategies for neurodegenerative diseases.

Their laboratories are equipped with state-of-the-art R&D facilities tailored to neuroscience technologies. Through their research, they aim to advance early diagnostics and gene therapy for neurodegenerative diseases. HKCeND's platform encompasses a range of activities, including the identification of novel biomarkers for disease diagnosis and monitoring, investigation of pathological mechanisms and therapeutic targets in Alzheimer's disease, as well as the determination of systemic factors and treatment strategies for the disease.

The brand is comprised of a team of leading scientists in neuroscience, stem cell biology, and artificial intelligence, who are committed to revolutionizing personalized healthcare. Their groundbreaking research has been recognized internationally, and they have even achieved a world-first application of artificial intelligence for early risk forecasting of Alzheimer's disease. If you have a passion for neuroscience and want to be at the forefront of this field, HKCeND offers exciting career opportunities for bright minds.

By joining their team, you can contribute to the pioneering work they are doing in the fight against neurodegenerative diseases. HKCeND is established under the Health@InnoHK cluster, which focuses on healthcare-related technologies. They are part of the Hong Kong Center for Neurodegenerative Diseases and are dedicated to making significant advancements in molecular diagnostics, bioinformatics, drug discovery, and personalized medicine.

Embrace the opportunity to be part of the HKCeND team and make a transformative impact on the future of neurodegenerative diseases